This week's sponsor is Premier Research. | | Taking the Fight to Rare Cancers
Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. |
Today's Rundown Featured Story | Monday, September 9, 2019 Amgen unveiled data for the highest dose of its KRAS inhibitor, showing it kept cancer at bay in 100% of lung cancer patients and shrank tumors in more than half of them. Though the data were impressive, Amgen's stock dipped in premarket trading. |
|
---|
|
Top Stories Monday, September 9, 2019 BARCELONA—Now within the ownership of Eli Lilly, Loxo Oncology has presented new data at the World Conference on Lung Cancer for its RET inhibitor LOXO-292 as it plots an NDA in the coming months. Monday, September 9, 2019 Tony Coles has taken up the CEO role at Pfizer spinout Cerevel Therapeutics. The appointment puts the man who led Onyx to a $10 billion takeover in charge of using $350 million of Bain Capital’s money to advance a pipeline of neuroscience programs. Monday, September 9, 2019 Patients want the best cancer therapies, and sites that enable clinical trials are the ones that can access those new drugs faster. Here’s how Monday, September 9, 2019 Joichi Ito has been forced out as head of the Media Lab at MIT as well as from biotech builder PureTech’s board after financial ties to the deceased sex offender Jeffrey Epstein were uncovered. Monday, September 9, 2019 Ayala Pharmaceuticals has hired AbbVie’s former vice president of oncology Gary Gordon, M.D., Ph.D., as its new chief medical officer. Monday, September 9, 2019 After a bumper series of private funding rounds, cancer biotech ADC Therapeutics is now looking to go public with a $150 million NYSE IPO attempt. Sunday, September 8, 2019 4BIO Capital plans to pump $50 million (€45 million), plus another $100 million it hopes to add by the final close, into companies that are working to extend use of advanced therapies to major diseases such as diabetes and rheumatoid arthritis. Friday, September 6, 2019 Although psychedelic drugs have shown promise in the treatment of multiple diseases, research into these compounds has been stymied. Johns Hopkins is trying to remedy that with a new, privately funded center for psychedelic research. Monday, September 9, 2019 Right now, Roche’s Tecentriq is the only immuno-oncology therapy approved in small cell lung cancer, but AstraZeneca’s Imfinzi added to standard-of-care chemo reduced newly diagnosed extensive-stage patients’ risk of death by 27% in a phase 3 study. Enrollment Showcase | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
---|
|
Resources Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. |